Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

Carneiro, B A; Collier, K A; Nagy, R J; Pamarthy, S; Sagar, V; Fairclough, S; Odegaard, J; Lanman, R B; Costa, R; Taxter, T; Kuzel, T M; Fan, A; Chae, Y K; Cristofanilli, M; Hussain, M H; Abdulkadir, S A; Giles, F J

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

Carneiro, B A; Collier, K A; Nagy, R J; Pamarthy, S; Sagar, V; Fairclough, S; Odegaard, J; Lanman, R B; Costa, R; Taxter, T; Kuzel, T M; Fan, A; Chae, Y K; Cristofanilli, M; Hussain, M H; Abdulkadir, S A; Giles, F J.

Afiliación

Carneiro BA; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Collier KA; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Nagy RJ; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Pamarthy S; Guardant Health, Inc., Redwood City, CA.
Sagar V; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Fairclough S; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Odegaard J; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Lanman RB; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Costa R; Guardant Health, Inc., Redwood City, CA.
Taxter T; Guardant Health, Inc., Redwood City, CA.
Kuzel TM; Guardant Health, Inc., Redwood City, CA.
Fan A; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Chae YK; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Cristofanilli M; Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Hussain MH; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Abdulkadir SA; Rush University Medical Center, Division of Hematology/Oncology, Chicago, IL.
Giles FJ; Stanford University School of Medicine, Palo Alto, CA.

JCO Precis Oncol ; 22018.

Article en En | MEDLINE | ID: mdl-31501807

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies / Screening_studies Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google